Navigation Links
Chemstrip Micral

ProductsChemstrip Micral
Company Roche Diagnostics
Item Chemstrip Micral
Features 
  • A fast, easy, one-minutes test to detect subclinical nephropathy
  • In-office testing
  • Proven accuracy compared to radioimmunoassay
  • Long- and short-term cost savings
  • Increased patient and physician satisfaction
Description Chemstrip Micral test strips are an optically read immunoassay to detect albumin in urine samples. When the test strip is dipped into a urine sample, urine passes via a wick fleece into the conjugate fleece. Any albumin present in the sample binds itself specifically to the gold-labeled antibodies.
Info Roche DiagnosticsCall Roche Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-415-6694

Customer Service: 1-800-428-5074
Web site: http://www.roche-diagnostics.com

Related medicine products :

1. Chemstrip 101 Urine Analyzer
...our practice with a practice management system. D...tronically or on paper. Your patient statements ca...mbined traditional software and billing services i...ny computer from anywhere - multiples offices or h...
...s lens incorporate 3 mirrors angled at 76°, 66...chamber as well as central and peripheral fundus v... are accurately angled and spaced 120° apart t...central portion of the lens also provides direct o...
...featuring ultra-clear Volk 3-Mirror optics, incorp...deg; and 60°. The 3 Mirror is ideal for anter...viewing and treatment. The retinal viewing mirrors...sualized fundus. The central portion of the lens a...
The AFX Lens is a direct image lens designed for use in an air-filled eye. In addition to its use as a primary air-fluid exchange vitrectomy lens, the low profile and sutureless design make it well s
Medicine Products:
(Date:7/18/2008)... ITHACA, N.Y. Behavior spanning the wide spectrum... the 12th International Behavioral Ecology Congres...ral Ecology, on Aug. 10 -14, 2008, at Cornell Univ...r sessions, the congress will feature plenary sess...ecology and evolutionary biology, Yale University,...
(Date:7/18/2008)... Giving children preventive antibiotics within on...reduces the risk for serious infections after the ...ished in the August issue of Pediatric Infectious...print). Children who received antibiotics outside ...times more likely to develop serious infections at...
(Date:7/18/2008)... VISTA, Calif., July 18 /PRNewswire/ -- Actress...ished herself as a tireless crusader in the search...egimens to help manage the,disease., McCarthy inc...p,specialty probiotic product, ThreeLac(TM), into ...her experience in her book Louder than,Words: A Mo...
(Date:7/18/2008)...Finding could help advance individualized medicine...ly 18 (HealthDay News) -- Scientists may have foun...y help determine whether or not they respond to th...cally, researchers at the Mayo Clinic have found t...ould help select which patients should try this dr...
Breaking Medicine News(10 mins):Health News:Averting postsurgical infections in kids: Give antibiotics within hour before first incision 2Health News:Global Health Trax Joins Fight Against Autism With Jenny McCarthy and Generation Rescue 2Health News:Gene Variations May Predict Antidepressant Response 2
..., have been cured at New Delhis Indraprastha Apoll...s, aged up to 18 years, were suffering from congen...year old child underwent an Intra Cardiac Echo (IC...tal, and was just among a handful in the country q...
...nd that two compounds from lobster shells, chitin ...erties. The researchers said that the compounds co...t healing and antiseptic properties, as well as to... and germination in seeds. Chitin is a very commo...
...odule received clearance from the U.S. Food and Dr...d its BBL(TM) broadband pulsed light received cle...resents the latest technological advancement from ...er energy to target fatty tissue. Using the ProLip...
... million soldiers, with the military to implement ... health scandals, state media reported on Friday. ...food products and eliminating the common practice ...same plate, according to an announcement by the Pe...
Other Medicine News:Health News:Lobster Shells Have Great Healing and Antiseptic Properties 2Health News:Sciton Receives FDA Clearance for Lipolysis and Wrinkle Treatment 2
(Date:7/16/2008)...ank discomfort as #1 reason to avoid discussing ED...disease, INDIANAPOLIS, July 16 /PRNewswire-FirstC... of men with erectile dysfunction (ED) surveyed,re...ons, such as heart,disease and diabetes, nearly 40...heir doctors. The survey, conducted by Ipsos Publi...
(Date:7/15/2008)...y 15 /- Abeome Corporation, a,Georgia...c equity,investment by Cato BioVentures and a coll...ract research and development organization. The in...nued development of Abeome,s lead,ovarian cancer p...mproves the development of,monoclonal antibodies a...
(Date:7/15/2008)...July 15 /- Alfacell Corpora...entered into a distribution,agreement with Megapha...l,for the commercialization of ONCONASE(R) (ranpi...g candidate, recently completed an international,c...able malignant,mesothelioma (UMM)., Under the agr...
(Date:7/14/2008)...ly 14 /- SyntheMed, Inc. (O...ngaged in the development,and commercialization of...urgical implants, announced today that REPEL-CV(R)...m for the reduction of adhesions,following cardiac...use in,pediatric patients who undergo open heart s...
Breaking Medicine Technology:The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 2The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 3The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 4The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 5Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel 2Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel 3Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel 4SyntheMed Receives Canadian Approval for REPEL-CV(R) 2Mayo Clinic study finds that after heart attack most patients stop taking life saving drugs 5519 1Mayo Clinic study finds that after heart attack most patients stop taking life saving drugs 5519 2New Computerized Scans Effective for Spotting Clogged Arteries 5516 1New Computerized Scans Effective for Spotting Clogged Arteries 5516 2New Computerized Scans Effective for Spotting Clogged Arteries 5516 3New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 753 1New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 753 2New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 753 3New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 753 4New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 753 5Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health 748 1Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health 748 2Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health 748 3
...ul 2, 2007 - Medtronic, Inc.,(NYSE:MDT) today ann...Clinical Trial indicates that the trial has met it... IV Clinical Trial is a randomized, single-blind,t...eavor(TM) Drug,Eluting Coronary Stent as compared ...tem from Boston Scientific Corporation,(NYSE:BSX)....
...ngoing therapeutic cancer vaccine,trials have yet ...quo;s immune system to shrink tumors -- yet patien...ve longer and respond,better to subsequent treatme...h, a journal of the American Association for Cance...searchers asks a,fundamental question: are we look...
Other Medicine Technology:ENDEAVOR IV Clinical Trial Meets Primary Endpoint 2From Clinical Cancer Research: Rethinking Therapeutic Cancer,Vaccine Trials 2From Clinical Cancer Research: Rethinking Therapeutic Cancer,Vaccine Trials 3